Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

Clinical trial NCT03296553 · COMPLETED

Trial details

NCT number: NCT03296553
Sponsor: National Institute of Cancerología
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Kaposi Sarcoma Human Immunodeficiency Virus Immune Reconstitution Syndrome

Start date: 2015-10-01
Primary completion: 2019-08-26
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.